MedBlog

Men's Health

What We Know About Your Prostate

• Claus Roehrborn, M.D.

November 9, 2018

Cancer

Prostate cancer genomic testing is flawed: Three reasons why

Men with prostate cancer want to know the future: Will my cancer get worse? Do I need surgery? Genomic testing can help us make educated recommendations, but it’s far from perfect. Claus Roehrborn, M.D., explains why genomic testing isn’t a “crystal ball” for predicting prostate cancer risk.

• Claus Roehrborn, M.D.

April 30, 2018

Cancer

Hormone therapy helps some prostate cancer survivors live longer

After prostate gland removal, cancer returns in up to 30% of men. But a 2017 study found that hormone-blockers plus radiation can prevent recurrence.

• Claus Roehrborn, M.D.
• Neil Desai, M.D.

February 8, 2017

Cancer

PSA tests: Can they save men from prostate cancer?

PSA blood tests are controversial in screening for prostate cancer. But Dr. Roehrborn says they save lives.

• Claus Roehrborn, M.D.

October 11, 2016

Cancer

UTSW teams exceed 1,000 targeted prostate biopsies

Dr. Claus Roehrborn and colleagues in Urology and Radiology are using a new, targeted biopsy method for prostate cancer that’s more effective than standard biopsies – and they’ve just reached a significant milestone.

• Claus Roehrborn, M.D.
• Ivan Pedrosa, M.D., Ph.D.

October 6, 2016